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ABSTRACT 
BACKGROUND AND OBJECTIVE: Streptococcus pneumoniae is one of the major pathogens responsible for 
invasive diseases such as pneumonia and meningitis. Epidemiological studies of these microorganisms are necessary to 
evaluate the effect of pneumococcal vaccine in any community. Therefore, the present study was conducted for molecular 
identification and detection of Streptococcus pneumoniae serotypes isolated from selected hospitals in Tehran using 
multiplex PCR method. 
METHODS: This cross-sectional study was performed on 32 isolates of Streptococcus pneumoniae from clinical 
specimens of patients admitted to different hospitals in Tehran. The isolates were identified by phenotypic tests and PCR 
method. Multiplex PCR was used to determine the serotype. 
FINDINGS: The number and percentage of Streptococcus pneumoniae isolates isolated from cerebrospinal fluid, 
sputum, blood, bronchoalveolar lavage, eyes, and nasal discharge were 12 (37.6%), 7 (21.8%), 6 (18.7%), 3 (9.5%), 2 
(6.2%), and 2 (6.2%) isolates, respectively. In the present study, the identified serotypes were the serotypes 1, 4, 6A/B, 
7F, 9V, 11A, 14, 15A, 19A, 19F, and 23F.   
CONCLUSION: Based on the results of this study, more than 50% of the serotypes were not among the serotypes 
present in the vaccines that are commonly used in the community. 
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Introduction 
Streptococcus pneumoniae (pneumococcus) bacterium 
can be colonized asymptomatically in the human 
nasopharynx, but this pathogen is one of the most 
important causes of invasive diseases such as 
pneumonia, septicemia, and meningitis (1, 2). Every 
year, this bacterium leads to the death of many people, 
which is estimated to be than 1.6 million, and is more 
commonly seen in children and the elderly (3). This 
bacterium is among gram – positive bacteria and has 
more than 90 serotypes. The most important and major 
factor of pneumococcal virulence is its polysaccharide 
capsule, which is the basis for its serotyping (4). By 
simultaneous comparison of isolates that causes 
invasive and noninvasive disease, it has been observed 
that pneumococcal pathogenesis is dependent on the 
type of capsular serotype. Among all serotypes, fifteen 
types are the most common serotypes that cause 
invasive disease in the host in most parts of the world 
(5, 6). Today, most vaccines against this bacterium are 
made from polysaccharide capsule. The first polyvalent 
vaccine, a seven-valent conjugate vaccine (PCV7), was 
licensed in 2000 (1).  
Serotypes in PCV7 include serotypes 4, 23F, 19F, 
18C, 14, 9V, and 6B. However, in order to increase the 
efficacy of the vaccine, 10 –  and 13 – Valent 
Pneumococcal Conjugate Vaccines are currently used; 
in addition to the aforementioned serotypes, these 
vaccines include serotypes 3, 1, 5, 6A, 7F, 19A (7). The 
World Health Organization has recommended the use of 
polyvalent vaccine against pneumococcus, since it 
includes the common serotypes (8). 
In developed European countries, this vaccine is 
designed and manufactured based on the serotype 
circulating in the community. To measure the efficacy 
of the vaccine and to evaluate the epidemiology of 
locally circulating serotypes, it is necessary to carry out 
epidemiologic studies regularly in each region at 
different times (9, 10). Several studies have shown that 
the serotypes that cause invasive diseases are highly 
diverse in different geographic regions. Even this 
diversity may be different in a geographic area at 
different times. The variety and diversity of serotypes in 
the use of vaccines can be of great importance, since the 
efficacy of each vaccine directly depends on the type of 
locally circulating serotype (11). In Iran, this vaccine 
has been imported from abroad and is injected into high-
risk groups, but one of the problems is that it is used in 
the community without conducting a study to show the 
serotypes. This leads to a reduction and sometimes 
ineffectiveness of the injected vaccine and leads to the 
development of dangerous diseases caused by this 
bacterium (such as meningitis and septicemia). In Iran, 
few studies have been conducted to determine the 
frequency of pneumococcal serotypes; there are only six 
recorded studies that were carried out from 1996 to 2018 
(10, 12–16). Considering the importance of the 
serotypes of this bacterium, the need for such 
epidemiological studies in different regions and times is 
necessary in Iran. Therefore, the present study was 
conducted for molecular identification and detection of 
Streptococcus pneumoniae serotypes isolated from 
selected hospitals in Tehran using multiplex PCR method.  
 
 
Methods 
Bacterial identification: In this cross-sectional study, 
32 pneumococcal isolates were collected from Milad, 
Mofid, Imam Sajjad and Sina Hospitals in Tehran 
during the years 2016 – 2017. The isolates were 
obtained from various samples including cerebrospinal 
fluid (CSF), sputum, blood, bronchoalveolar lavage 
(BAL), eyes, and nasal discharge. In the following step, 
isolates cultured on 5% sheep blood agar plate that were 
phenotypically similar to Streptococcus pneumoniae 
were identified by gram staining, catalase test, bile 
solubility test, and Optochin sensitivity test. As a 
qualitative control, the standard Streptococcus 
pneumoniae strain ATCC 49619 was used. For storage, 
isolates were stored in a STGG medium (Merck, 
Germany) at a temperature of - 70 °C.  
DNA extraction: Bacterial isolates were dissolved in 
250 μl phosphate buffered saline (PBS) and DNA was 
extracted according to the instructions of Roche kit 
(Germany). The extracted DNA was evaluated using 
nanodrop and electrophoresis in 1% gel.   
PCR: In this study, PCR method was used to confirm 
the isolates of Streptococcus pneumoniae. In the present 
study, capsular polysaccharide biosynthesis protein 
CpsA was used to identify Streptococcus pneumoniae 
(17). In this study, the HotStarTaq Master Mix Kit 
(SinaClone, Iran) was used to perform the PCR reaction.  
Multiplex PCR serotyping: Multiplex PCR was used 
to determine the serotype in pneumococcal isolates. 
Twenty – five primer pairs were used for this purpose 
(Table 1). Seven Multiplex PCR reactions were 
performed (Table 2). The primers used in this study 
were grouped and selected based on the frequency of 
serotypes that are the cause of invasive diseases as well 
as the strains found in vaccines (7 –, 10 – and 13 – 
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Valent Vaccines). After performing Multiplex PCR, the 
products were electrophoresed in 2% gel.  
Statistical analysis: Data were analyzed using SPSS 
19, Wilcoxon, and Chi-square tests and p < 0.05 was 
considered significant. 
 
 
Results 
Pneumococcal isolates collected from different 
specimens included: 12 isolates (37.6%) of CSF, 7 
isolates (21.8%) of sputum, 6 isolates (18.7%) blood, 3 
isolates (9.5%) of BAL, 2 isolates (6.2%) of the eyes, 
and 2 isolates (6.2%) of the nasal discharge. 19 (59.4%) 
patients were male and 13 (40.6%) patients were 
female, while 22 (69%) patients were children. In this 
study, twenty–five common serotypes were studied. 
The identified serotypes were 1, 4, 6A/B, 7F, 9V, 11A, 
14, 15A, 19A, 19F, and 23F. The pneumococcal isolates 
whose serotype was identified were collected from 
clinical specimens of CSF (6 isolates), blood (3 
isolates), sputum (2 isolates), BAL (1 isolate) and nasal 
discharge (1 isolate).  
The most frequent serotype was 6A/B, and this 
serotype was more isolated from adults. Based on the 
results of this study, of 32 evaluated pneumococcal 
isolates, 19 isolates (59%) were not among any of the 
evaluated 25 serotypes. In other words, these isolates 
were non-typeable in this study. Chi-square and 
Wilcoxon tests did not show significant correlation 
between gender (p=0.26), type of clinical specimen 
(p=0.38), age (p=0.56) of patients, and the used 
serotype.  
 
Table 1. Sequencing of primers for serotyping of pneumococcal isolates using Multiplex PCR (10) 
bands size range (bp) Primer sequence 5′ to 3′ Name of primer 
280 
CTC TAT AGA ATG GAG TAT ATA AAC TAT GGT TA 
CCA AAG AAA ATA CTA ACA TTA TCA CAA TAT TGG C 
1-F 
1-R 
430 
CTG TTA CTT GTT CTG GAC TCT CGA TAA TTG G 
GCC CAC TCC TGT TAA AAT CCT ACC CGC ATT G 
4-F 
4-R 
371 
ATG GTG TGA TTT CTC CTA GAT TGG AAA GTA G 
CTT CTC CAA TTG CTT ACC AAG TGC AAT AAC G 
3-F 
3-R 
362 
ATA CCT ACA CAA CTT CTG ATT ATG CCT TTG TG 
GCT CGA TAA ACA TAA TCA ATA TTT GAA AAA GTA TG 
5-F 
5-R 
250 
AAT TTG TAT TTT ATT CAT GCC TAT ATC TGG 
TTA GCG GAG ATA ATT TAA AAT GAT GAC TA 
6A/B-F 
6A/B-R 
826 
CCT ACG GGA GGA TAT AAA ATT ATT TTT GAG 
CAA ATA CAC CAC TAT AGG CTG TTG AGA CTA AC 
7F-F 7F-R 
260 
CTA TCT CAG TCA TCT ATT GTT AAA GTT TAC GAC GGG A 
GAA CAT AGA TGT TGA GAC ATC TTT TGT AAT TTC 
7C-F 
7C-R 
294 
GAT GCC ATG AAT CAA GCA GTG GCT ATA AAT C 
ATC CTC GTG TAT AAT TTC AGG TAT GCC ACC 
8-F 
8-R 
753 
CTT CGT TAG TTA AAA TTC TAA ATT TTT CTA AG 
GTC CCA ATA CCA GTC CTT GCA ACA CAA G 
9V-F 
9V-R 
628 
GGT GTA GAT TTA CCA TTA GTG TCG GCA GAC 
GAA TTT CTT CTT TAA GAT TCG GAT ATT TCT C 
10A-F 
10A -R 
463 
GGA CAT GTT CAG GTG ATT TCC CAA TAT AGT G 
GAT TAT GAG TGT AAT TTA TTC CAA CTT CTC CC 
11A-F 
11A -R 
376 
GCA ACA AAC GGC GTG AAA GTA GTT G 
CAA GAT GAA TAT CAC TAC CAA TAA CAA AAC 
12F-F 
12F -R 
208 
CTT GGC GCA GGT GTC AGA ATT CCC TCT AC 
GCC AAA ATA CTG ACA AAG CTA GAA TAT AGC C 
14-F 
14-R 
436 
ATT AGT ACA GCT GCT GGA ATA TCT CTT C 
GAT CTA GTG AAC GTA CTA TTC CAA AC 
15B-F 
15B-R 
988 
TTG GAA TTT TTT AAT TAG TGG CTT ACC TA 
CAT CCG CTT ATT AAT TGA AGT AAT CTG AAC C 
16F-F 
16F-R 
693 
TTC GTG ATG ATA ATT CCA ATG ATC AAA CAA GAG 
GAT GTA ACA AAT TTG TAG CGA CTA AGG TCT GC 
17F-F 
17F-R 
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bands size range (bp) Primer sequence 5′ to 3′ Name of primer 
573 
CTT AAT AGC TCT CAT TAT TCT TTT TTT AAG CC 
TTA TCT GTA AAC CAT ATC AGC ATC TGA AAC 
18C-F 
18C-R 
478 
GTT AGT CCT GTT TTA GAT TTA TTT GGT GAT GT 
GAG CAG TCA ATA AGA TGA GAC GAT AGT TAG 
19A-F 
19A-R 
304 
GTT AAG ATT GCT GAT CGA TTA ATT GAT ATC C 
GTA ATA TGT CTT TAG GGC GTT TAT GGC GAT AG 
19F-F 
19F-R 
514 
GAG CAA GAG TTT TTC ACC TGA CAG CGA GAA G 
CTA AAT TCC TGT AAT TTA GCT AAA ACT CTT ATC 
20-F 
20-R 
384 
GTA ACA GTT GCT GTA GAG GGA ATT GGC TTT TC 
CAC AAC ACC TAA CAC ACG ATG GCT ATA TGA TTC 
23F-F 
23F-R 
701 
GGA AGT TTT CAA GGA TAT GAT AGT GGT GGTGC 
CCG AAT AAT ATA TTC AAT ATA TTC CTA CTC 
31-F 
31-R 
408 
GCT TTT GTA AGA GGA GAT TAT TTT CAC CCA AC 
CAA TCC GAC TAA GTC TTC AGT AAA AAA CTT TAC 
34-F 
34-R 
677 
GAT AAG TCT GTT GTG GAG ACT TAA AAA GAA TG 
CTT TCC AGA TAA TTA CAG GTA TTC CTG AAG CAA G 
35B-F 
35B-R 
517 
GAA CAT AGT CGC TAT TGT ATT TTA TTT AAA GCA A 
GAC TAG GAG CAT TAT TCC TAG AGC GAG TAA ACC 
35F-F 
35F-R 
 
Table 2. General scheme of the grouping of primers based on Multiplex PCR method 
Primer Melting Temperature Bands size range (bp) Primers Volume of primer (µl) Reaction 
62 °C 
478 
304 
250 
280 
160 
19A 
19F 
6A/B 
1 
cps 
2 
2 
2 
2 
2 
1 
63 °C 
362 
208 
826 
753 
5 
14 
7F 
9V 
2 
2 
2 
2 
2 
63 °C 
384 
826 
463 
280 
160 
F23 
7F 
11A 
1 
cps 
3 
4 
2 
2 
2 
3 
62 °C 
988 
573 
677 
376 
16F 
18C 
35B 
12F 
4 
2.5 
2 
2 
4 
61 °C 
294 
371 
496 
701 
8 
3 
15B 
31 
3 
3 
3 
4 
5 
60 °C 
280 
628 
517 
408 
1 
10A 
35F 
34 
3 
3 
3 
4 
6 
63 °C 
514 
260 
693 
430 
20 
7C 
17F 
44 
2 
2 
2 
2 
7 
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Discussion 
Based on the obtained results, of 32 evaluated 
pneumococcal isolates, 19 isolates (59%) were not 
among the strains in 7 –, 10 – and 13 – Valent Vaccines. 
In other words, these isolates were non-typeable strains. 
In this study, the prevalence of the most common 
serotypes in the world has been investigated; the ones 
that are also present in 7 –, 10 – and 13 – Valent 
Vaccines. Determination of the serotypes of 
Streptococcus pneumoniae is critical for proper 
immunization in people at risk and for the development 
of vaccine (18).  
In a study by Habibian et al. in Tehran, the highest 
prevalence of serotypes was related to serotypes 14, 3, 
23F, 19F, 19A, 6A, 9V, and 6B, respectively (19). 
Comparing the results of this study and the study 
present, the prevalence of serotypes 6A, 9V, 14, 19F and 
23F was similar. In the study of Mousavi et al. in 
Tehran, the most frequent serotypes were 23F, 3, 6, 19A 
among the studied serotypes (20). In another study in 
Tehran conducted by Houri et al., the frequency of 
serotypes was 23F, 19F, 19A and 9V (10); comparing 
the results of these two studies with our study showed 
that the prevalence of serotypes 6A, 9V, 19A, 19V and 
23F are the same.  
The similarity in the prevalence of serotypes is due 
to the fact that the location of the study is similar. 
Another similarity between these two studies and our 
research is serotyping method, which is the Multiplex 
PCR method, but the difference in the prevalence of 
other serotypes is due to the difference in the time of the 
study. Finding such differences confirms the need for 
consistent follow-up for serotypes.  
Except for the two mentioned studies, no similar 
study was found that evaluated pneumococcal serotypes 
in clinical specimens and therefore more studies should 
be conducted to detect pneumococcal serotypes in 
clinical isolates. In a study in Turkey, the most common 
serotypes were 19F, 6B, 23F, and 18C (21). Comparison 
of these studies shows that three common serotypes in 
Turkey are also present in Iran. However, 18C serotype 
was not observed in our study. In a study conducted in 
Saudi Arabia, the highest frequency was related to 
strains 4, 3, 19F, 9V, 19A and 14 (22). The prevalence 
of pneumococcal serotypes in Saudi Arabia is very 
similar to our study. The possible reason for this is 
because of the pilgrimage of Iranians to the city of 
Mecca, and when the carriers of bacteria return to Iran, 
they spread the strains in the community. In Pakistan, 
the highest frequency of serotypes was reported for 18, 
14 and 19F (23). There are fewer similar serotypes 
compared to our study, which may confirm the theory 
that the travel of Iranian people to neighboring countries 
or vice versa has a major role in the diffusion of 
different strains of pneumococcus in Iran. One of the 
significant findings in this study was the isolation of 
serotypes 1, 4, 7F and 15A. According to evaluations in 
other studies, these serotypes have rarely been reported 
in Iran (21).  
One of the reasons for the differences in the results 
of the studies may be due to the fact that these studies 
were conducted at different points in time. The second 
reason for difference in the results is due to the number 
of the studied samples, since the sample size was 
different in each of the studies. Among the limitations 
of this study was small number of pneumococcal 
isolates due to the slow-growing bacterium. Based on 
the results of this study, it should be noted that more 
than half of the pneumococcal isolates were not part of 
the serotypes in vaccines used for immunization of 
children in Iran. For matching different studies in Iran, 
it is suggested that similar sample size be used by 
different studies so that we can make a reasonable 
comparison based on the obtained results.  
Considering the importance of Streptococcus 
pneumoniae in causing diseases with high mortality, 
such as septicemia and meningitis, and also the 
correlation between the serotype and the type of 
complication that leads to it (24, 25), it is necessary to 
evaluate the prevalence of serotypes of this bacterium in 
Iran. Then, vaccination should be done in people at risk, 
such as children and the elderly. In Iran, like other 
countries of the world, the supply and administration of 
polyvalent pneumococcal vaccines should be based on 
the type of circulating serotype, in which case the 
immunization of individuals will be fully done. Because 
of the limited information on the prevalence of 
pneumococcal serotypes in Iran, it is suggested that the 
prevalence of pneumococcal serotypes be tracked in all 
regions of the country for several consecutive years and 
a suitable polyvalent pneumococcal vaccine be 
introduced and used based on the obtained results.  
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